Under construction – not a live service
Sign in
Not yet taking people in ChinaNo phase

MRI Scans to Predict Survival in Cervical Cancer Patients Given Radiotherapy

Studies whether MRI scans can predict survival in women with cervical cancer treated with radiation.

Plain-language title generated from the registry record
Registry title: MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy

Key facts

Where
Fuzhou, ChinaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 20 to 85 with cervical cancer confirmed by pathology, treated for the first time at the study center.

Age
20 Years to 85 Years
Sex
Women only
Disease stage
Cervical cancer confirmed by pathology (biopsy or tissue examination).
Earlier treatment
First treatment at the study center. People with earlier anti-tumor treatment or earlier pelvic surgery cannot join.

Main reasons for not taking part

  • No MRI scan before treatment
  • Earlier anti-tumor treatment
  • Earlier pelvic surgery
  • Incomplete therapy
  • Lost to follow-up

Read by machine on 9 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 85 years old?

Source: NCT06197126, who can take part

Where in China

  • Fujian Cancer HospitalFuzhou, ChinaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Fujian Cancer Hospital
Trial code
NCT06197126
Record updated
9 January 2024
Original description
This study aims to validate the value of tumor involvement features based on MRI in cervical cancer, facilitate the development of a more appropriate model for risk stratification, and help patients with varying risk profiles make appropriate decisions in treatment selection and follow-up plans.Read full original descriptionShow less

A Prognostic Model Based on MRI for Cervical Cancer Patients Treated With Radiotherapy

This study aims to validate the value of tumor involvement features based on MRI in cervical cancer, facilitate the development of a more appropriate model for risk stratification, and help patients with varying risk profiles make appropriate decisions in treatment selection and follow-up plans.

Inclusion: (1) pathologically confirmed CC, (2) initially treated in our center.

Exclusion: (1) lack of pre-treatment MRI, (2) prior anti-tumor treatment, (3) pelvic surgery history, (4) incomplete therapy, (5) loss of follow-up.

ClinicalTrials.gov NCT06197126